Seattle Prostate Institute

Blasko JC, Grimm PD, Sylvester JE, Badiozamani KR, Hoak D, Cavanagh W. Palladium-103 Brachytherapy for Prostate Cancer Int. J Radiation Oncology Biol. Phys. 2000;46(4):839-850.

Sylvester JE, Blasko JC, Grimm PD, Meier R, Cavanagh W. Short Course Androgen Ablation Combined with External Beam Radiation Therapy and Low Dose Rate Permanent Brachytherapy in Early Stage Prostate Cancer: A Matched Subset Analysis. Molecular Urology 2000;4(3):155-9: Discussion 161.

Cavanagh W, Blasko JC, Grimm PD, Sylvester JE. Transient Elevation of Serum Prostate- Specific Antigen Following 125I/103Pd Brachytherapy for Localized Prostate Cancer. Seminars in Urologic Oncology 2000;18(2):160-165.

Blasko JC, Grimm PD, Sylvester JE, Cavanagh W. The Role of External Beam Radiotherapy With I-125/Pd-103 Brachytherapy for Prostate Carcinoma Radiotherapy & Oncology 2000;57:273-278.

Sylvester JE, Grimm PD, Blasko JC, Meier R, Grier D, Heaney C, Cavanagh W. Urethral Visualization During Transperineal Interstitial Brachytherapy for Early Stage Prostate Cancer. Journal of Brachytherapy International 2000;16:145-150.

Beyer D, Ravinder N, Butler W, Merrick G, Blasko JC, Nag S, Orton C. American Brachytherapy Society Recommendations For Clinical Implementation of NIST-1999 Standards For Palladium Brachytherapy. Int. J. Radiation Oncology Biol. Phys 2000;47(2):273-275.

Sylvester JE, Grimm PD, Blasko JC, Meier R, Spiegel J, Heaney C, Cavanagh W. The Role of Androgen Ablation in Patients With Biochemical or Local Failure After Definitive Radiation Therapy: A Survey of Practice Patterns of Urologists and Radiation Oncologists in the United States. Molecular Urology 2001;58(2A):71-77.

Grimm PD, Blasko JE, Sylvester JE. Clinical Selection Issues for Permanent Seed Prostate Brachytherapy. J. of Brachytherapy International 2001;16(3):143-152.

Sylvester JE, Blasko JE, Grimm PD, Meier R, Heaney C, Cavanagh W. Impact of Short-Course Androgen Ablation on the Biochemical Progression-Free Survival of High-Risk Prostate Cancer Patients Managed With Permanent Brachytherapy J. of Brachytherapy International July 2001;16(2):173-180.

Sylvester JE, Blasko JC, Grimm PD, Meier R. Transperineal Permanent Brachytherapy for Local Recurrence Following External Beam Radiation for Early Stage Prostate Cancer. J. of Brachytherapy International 2001;16(2):181-188.

Grimm PD, Sylvester JE. Permanent Seed Brachytherapy in Patients With Advanced Prostate Cancer: Current Strategies. Advances in Prostate Cancer 2001;5(2).

Kattan MW, Potters L, Blasko JC, Beyer DC, Fearn P, Cavanagh W, Leibel S, Scardino PT. Pretreatment Nomogram For Predicting Freedom From Recurrence After Permanent Prostate Brachytherapy in Prostate Cancer. Urology 2001;58(3):393-399.

Campbell T, Blasko JC, et al. Clinical Staging of Prostate Cancer: Reproducibility and Clarification of Issues. International J. Cancer Radiation Oncology 2001;96:198-209.

Grimm PD, Blasko JC, Sylvester JE, Meier RM, Cavanagh W. 10-Year Biochemical (Prostate-Specific Antigen) Control of Prostate Cancer. International. J. Radiation Oncology 2001;51(1):31-40.

Sylvester JE, Blasko JC, Grimm PD. Brachytherapy as Monotherapy, In: Koss, Isaacs & Scher, editors. Prostate Cancer Principles & Practice. Philadelphia, PA: Lippincott, Williams & Wilkins; 2002;336-357.

Blasko JC, Mate T, Sylvester JE, Grimm PD, Cavanagh W. Brachytherapy for Carcinoma of the Prostate: Techniques, Patient Selection, and Clinical Outcomes. Seminars in Radiation Oncology 2002;12(1):81-94.

Bagley Jr CM, Lane RF, Blasko JC, Grimm PD, Ragde H, Cobb OE, Rowbotham RK. Adjuvant Chemohormonal Therapy of High Risk Prostate Carcinoma Ten Year Results. Cancer 2002;94(10):2728-2732.

Sylvester JE, Blasko JC, Grimm PD, et al. Ten-Year Biochemical Relapse-Free Survival Following External Beam Radiation and Brachytherapy for Localized Prostate Cancer: The Seattle Experience. International Journal of Radiation Oncology Biology Physics 2003;57:4:944-952.

Han BH, Wallner K, Merrick G, Butler W, Sutlief S, Sylvester J., Prostate Brachytherapy Seed Identification On Post-Implant TRUS Images. Medical Physics, 2003;30(5):898-900.

Sylvester J, Blasko J, Grimm P. In: D�Amico A, Loeffler J, Harris J, editors. Transrectal Ultrasound-Guided Prostate Brachytherapy. Image-Guided Diagnosis and Treatment of Cancer. Totowa: Humana Press; 2003;119-154.

Grimm PD, Sylvester JE, Blasko JC, et al. Prostate Seed Implantation for Prostate Cancer. PCR Insights November 2003;6(4):1-9, 12-13.

Grimm PG, Blasko JC, Sylvester JE. In: The Prostate Cancer Treatment Book. New York: McGraw Hill; 2004.

Sylvester JE. Prostate Brachytherapy. North American Pharmaco Therapy, Business Briefing February 2004;51-53.

Grimm PD, Blasko JC, Sylvester JE, et al. Technical Improvement in Permanent Seed Implantation: A Two Stage Brachytherapy System. Description and Comparison With Current Technique. Brachytherapy 2004;3(1):34-40.

Sylvester JE, Blasko JC, Grimm PD, et al. Fifteen Year Follow up of the First Cohort of Localized Prostate Cancer Patients Treated With Brachytherapy. Journal of Clinical Oncology 2004;22(Suppl. 14):4567.

Grimm PD, Sylvester JE. Advances in Brachytherapy. Reviews in Urology 2004;6(Suppl. 4):S37-S48.

Grimm PD, Ryan RA, Stern EM, Belland A, Page JA, Barrett P. The effect of Income on Prostate Cancer Patient�s Awareness and Discussion Levels of Treatment Options. [Abstract]. American Society for Therapeutic Radiology and Oncology 46th Annual Meeting, Atlanta, GA October 2004.

Sylvester JE. The Seattle Prostate Institute Approach to Treatment Planning for Permanent Implants: In: Dicker AP et al., editors. Basic and Advanced Techniques in Prostate Brachytherapy. Independence, KY: Martin Dunitz Taylor & Francis Group; 2005.

Sylvester JE, Blasko JC, Grimm PD, et al. Fifteen Year Outcomes of Prostate Cancer Patients Treated With Brachytherapy. BJU [Abstract] 2005.

Ellis WJ, Blasko JC. Interstitial Radiation Therapy. In: Vaughan, Perlmutter, editors. Atlas of Clinical Urology, Volume 2 The Prostate. Philadelphia, PA: Current Medicine Inc; 13.2-13.8.

Sylvester JE, Valicenti RK. Review of article. Hormonal Therapy Plus External-Beam Radiation and Brachytherapy for Prostate Cancer. Oncology 19(1):36-39

Vermeulen S, Young R, Posewitz A, Grimm P, Blasko JC, E. Kohler, Raisis J. Stereotactic Radiosurgery Toxicity in Treatment of Intracanalicular Acoustic Neuromas: The Seattle Northwest Gamma Knife Experience. Stereotact Funct Neurosurg 70(suppl. 1):80-87.

Carroll PR, Fair WR, Grossfeld GD, Heston WD, Lieberman R, Malkowicz SB, Stricker HJ, Sylvester J, Peehl DM, Meyer F, Hard C. Overview consensus statement. Urol 58:1-4.

Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD, �Second Malignancies After Prostate Brachytherapy: Incidence of Bladder and Colorectal Cancers in Patients with Fifteen Years of Potential Follow-up�; International Journal of Radiation Oncology Biology Physics 2006;66:3:669-673.

Sylvester JE, Grimm PG, Blasko JC, Millar J, Orio III PF, Skoglund S, Galbreath RW, Merrick G, �15-Year Biochemical Relapse Free Survival in Clinical Stage T1-T3 Prostate Cancer Following Combined External Beam Radiotherapy and Brachytherapy; Seattle Experience�; International Journal of Radiation Oncology Biology Physics 2007;67:1:57-64.

Merrick GS, Grimm PD, Sylvester J, Blasko JC, et al. �Initial analysis of Pro-Qura: A multi-institutional database of prostate brachytherapy dosimetry,� Brachytherapy 2007; 6(1):9-15.

Steven J. Frank, Peter D. Grimm, John E. Sylvester, Gregory S. Merrick, Brian J. Davis, Anthony Zeitman, Brian J. Moran, David C. Beyer, Mack Roach III, Daniel H. Clarke, Richard G. Stock, W. Robert Lee, Jeff M. Michalski, Kent E. Wallner, Mark Hurwitz, Louis Potters, Deborah A. Kuban, Bradley R. Prestidge, Robyn Vera, Shannon Hathaway, John C. Blasko. �Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the United States,� Brachytherapy 2007; 6(1):2-8.

John Sylvester, Tricia Zeller, Chris J. Hennessy, Steve Eulau, Peter Grimm. Overview of the Calypso^� 4D Localization System�; American College of Radiation Oncology Practice Management Guide, American College of Radiation Oncology, Bethesda, MD 2008.